Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Spence

Showing results (201-210 of 207) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 207 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 22, 2020
High-intensity interval training in patients with left ventricular assist devices: A pilot randomized controlled trialIgnacio Moreno-Suarez, Anna Scheer, Kaitlyn Lam, et al.
Bioconjugate Chemistry|April 21, 2001
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis CP Bailon, A Palleroni, C A Schaffer, et al.
Journal of Medicinal Chemistry|April 22, 2010
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)Nancy-Ellen Haynes, Wendy L Corbett, Fred T Bizzarro, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 17, 2022
Impact of restricted visitation policies during COVID-19 on critically ill adults, their families, critical care clinicians, and decision-makers: a qualitative interview studyKirsten M Fiest, Karla D Krewulak, Natalia Jaworska, et al.
Science (New York, N.Y.)|July 19, 2003
Allosteric activators of glucokinase: potential role in diabetes therapyJoseph Grimsby, Ramakanth Sarabu, Wendy L Corbett, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 2021
An environmental scan of visitation policies in Canadian intensive care units during the first wave of the COVID-19 pandemicKirsten M Fiest, Karla D Krewulak, Carmen Hiploylee, et al.
Journal of Medicinal Chemistry|July 20, 2012
Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patientsRamakanth Sarabu, Fred T Bizzarro, Wendy L Corbett, et al.
Pageof 21

Showing results (201-210 of 207) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 207 results.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 22, 2020
High-intensity interval training in patients with left ventricular assist devices: A pilot randomized controlled trialIgnacio Moreno-Suarez, Anna Scheer, Kaitlyn Lam, et al.
Bioconjugate Chemistry|April 21, 2001
Rational design of a potent, long-lasting form of interferon: a 40 kDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis CP Bailon, A Palleroni, C A Schaffer, et al.
Journal of Medicinal Chemistry|April 22, 2010
Discovery, structure-activity relationships, pharmacokinetics, and efficacy of glucokinase activator (2R)-3-cyclopentyl-2-(4-methanesulfonylphenyl)-N-thiazol-2-yl-propionamide (RO0281675)Nancy-Ellen Haynes, Wendy L Corbett, Fred T Bizzarro, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|August 17, 2022
Impact of restricted visitation policies during COVID-19 on critically ill adults, their families, critical care clinicians, and decision-makers: a qualitative interview studyKirsten M Fiest, Karla D Krewulak, Natalia Jaworska, et al.
Science (New York, N.Y.)|July 19, 2003
Allosteric activators of glucokinase: potential role in diabetes therapyJoseph Grimsby, Ramakanth Sarabu, Wendy L Corbett, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 1, 2021
An environmental scan of visitation policies in Canadian intensive care units during the first wave of the COVID-19 pandemicKirsten M Fiest, Karla D Krewulak, Carmen Hiploylee, et al.
Journal of Medicinal Chemistry|July 20, 2012
Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patientsRamakanth Sarabu, Fred T Bizzarro, Wendy L Corbett, et al.
Pageof 21